316 related articles for article (PubMed ID: 31827470)
1. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
Front Immunol; 2019; 10():2741. PubMed ID: 31827470
[TBL] [Abstract][Full Text] [Related]
2. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
[TBL] [Abstract][Full Text] [Related]
3. Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.
Wren L; Parsons MS; Isitman G; Center RJ; Kelleher AD; Stratov I; Bernard NF; Kent SJ
PLoS One; 2012; 7(6):e38580. PubMed ID: 22701674
[TBL] [Abstract][Full Text] [Related]
4. Deficient IL-2 Produced by Activated CD56
Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
Front Immunol; 2019; 10():1647. PubMed ID: 31379845
[No Abstract] [Full Text] [Related]
5. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
6. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
[TBL] [Abstract][Full Text] [Related]
7. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
Mielke D; Stanfield-Oakley S; Borate B; Fisher LH; Faircloth K; Tuyishime M; Greene K; Gao H; Williamson C; Morris L; Ochsenbauer C; Tomaras G; Haynes BF; Montefiori D; Pollara J; deCamp AC; Ferrari G
J Virol; 2022 Jan; 96(2):e0164321. PubMed ID: 34730393
[TBL] [Abstract][Full Text] [Related]
8. Obstacles to ideal anti-HIV antibody-dependent cellular cytotoxicity responses.
Wren LH; Stratov I; Kent SJ; Parsons MS
Vaccine; 2013 Nov; 31(47):5506-17. PubMed ID: 23981432
[TBL] [Abstract][Full Text] [Related]
9. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
Pollara J; Hart L; Brewer F; Pickeral J; Packard BZ; Hoxie JA; Komoriya A; Ochsenbauer C; Kappes JC; Roederer M; Huang Y; Weinhold KJ; Tomaras GD; Haynes BF; Montefiori DC; Ferrari G
Cytometry A; 2011 Aug; 79(8):603-12. PubMed ID: 21735545
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity.
Isitman G; Lisovsky I; Tremblay-McLean A; Parsons MS; Shoukry NH; Wainberg MA; Bruneau J; Bernard NF
AIDS; 2015 Jul; 29(12):1433-43. PubMed ID: 26244383
[TBL] [Abstract][Full Text] [Related]
11. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
12. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.
Parsons MS; Madhavi V; Ana-Sosa-Batiz F; Center RJ; Wilson KM; Bunupuradah T; Ruxrungtham K; Kent SJ
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):17-23. PubMed ID: 26761269
[TBL] [Abstract][Full Text] [Related]
14. Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.
Mayr LM; Decoville T; Schmidt S; Laumond G; Klingler J; Ducloy C; Bahram S; Zolla-Pazner S; Moog C
Sci Rep; 2017 Oct; 7(1):12655. PubMed ID: 28978939
[TBL] [Abstract][Full Text] [Related]
15. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
[TBL] [Abstract][Full Text] [Related]
16. Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.
Joachim A; Nilsson C; Aboud S; Bakari M; Lyamuya EF; Robb ML; Marovich MA; Earl P; Moss B; Ochsenbauer C; Wahren B; Mhalu F; Sandström E; Biberfeld G; Ferrari G; Polonis VR
PLoS One; 2015; 10(4):e0118486. PubMed ID: 25874723
[TBL] [Abstract][Full Text] [Related]
17. Immunization with Clinical HIV-1 Env Proteins Induces Broad Antibody Dependent Cellular Cytotoxicity-Mediating Antibodies in a Rabbit Vaccination Model.
Karlsson I; Borggren M; Jensen SS; Heyndrickx L; Stewart-Jones G; Scarlatti G; Fomsgaard A
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):206-217. PubMed ID: 28982260
[TBL] [Abstract][Full Text] [Related]
18. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
Front Immunol; 2020; 11():1274. PubMed ID: 32733445
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
Ahmad A; Morisset R; Thomas R; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
[TBL] [Abstract][Full Text] [Related]
20. Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial.
Tolbert WD; Van V; Sherburn R; Tuyishime M; Yan F; Nguyen DN; Stanfield-Oakley S; Easterhoff D; Bonsignori M; Haynes BF; Moody MA; Ray K; Ferrari G; Lewis GK; Pazgier M
mBio; 2020 Jun; 11(3):. PubMed ID: 32605979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
